2-(5-Isobutyl-2-methylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACOFEX069
CAS No. :
2223042-73-5
Molecular Formula :
C15H25BO2S
Molecular Weight :
280.24

IUPAC Name:2-(5-isobutyl-2-methylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(5-Isobutyl-2-methylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-Isobutyl-2-methylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(5-isobutyl-2-methylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular FormulaC15H25BO2S
Molecular Weight280.24
SMILESCC(SC(CC(C)C)=C1)=C1B2OC(C)(C)C(C)(C)O2
InChI KeyTYDPRUBZMAWEQL-UHFFFAOYSA-N
Synonym2-Methyl-5-(iso-butyl)thiophene-3-boronic acid pinacol ester;1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[2-methyl-5-(2-methylpropyl)-3-thienyl]-
CAS No.2223042-73-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOFEX069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOFEX069 route product structure diagram
    ACOFEX0692223042-73-5
Inquiry

2. ACOFEX069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOFEX069 route product structure diagram
    ACOFEX0692223042-73-5
Inquiry

Comments (0)